Pharmacy and Wellness Review
Volume 16, Issue 2 (2025) Spring 2025
Addressing Socioeconomic Disparities in the Treatment of Antimicrobial-Resistant Infections: The Role of Pharmacists in Mitigating Barriers
Arin Wade, Danielle Egbujor, Anna Spalvieri, Owen Fox, Marisa Petrunich, Joshua Honaker, Samantha McCord, and Kasie Landin
Spravato® FDA-Approved as Monotherapy for Adults with Treatment-Resistant Depression
Rileigh Rahrig, Kennedy Kosikowski, Haylee Whyde, Kiley Devoll, Allie Honigford, Macy Davis, Joshua Honaker, Samantha McCord, and Manoranjan D'Souza
Misused and Misunderstood: Examining the Inappropriate Use of Stimulant Medications
Connor Dains, Madilyn Paphanchith, Makayla Eversole, Chaehyeon Jin, Minhwan Yang, Joshua Honaker, Samantha McCord, and Kayla Petkus
FDA Approval of Cobenfy: A New Therapeutic Option for Schizophrenia
Brenna Hissong, Penlope Mazivanhanga, Alexander DeFranco, Linda Azap, Haley Brown, Megan Rizo, Joshua Honaker, Samantha McCord, and Lindsey Ferraro
FDA Approves Lecanemab-irmb Maintenance Dosing for Early Alzheimer’s Disease Treatment
Jordyn Linfield, Giang Nguyen, Ashley Jacob, Andrew Johnson, Maria Nguyen, Sara Ha, Joshua Honaker, Samantha McCord, and Kelly Kroustos
Editors
- Editor-in-Chief
- Joshua Honaker
- Managing Editor
- Samantha McCord
- Lead Editors
- Arin Wade
- Rileigh Rahrig
- Brenna Hissong
- Connor Dains
- Jordyn Linfield
- Original Website Editor
- Emily Wells
Faculty Advisors
- Karen L. Kier, BSPh, Ph.D., R.Ph., BCPS, BCACP
- Original Journal Layout
- Darlene Bowers